Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion type Assertion NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_head.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion wasGeneratedBy ECO_0000203 NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_provenance.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion wasDerivedFrom befree-2016 NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_provenance.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion SIO_000772 9372085 NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_provenance.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion evidence source_evidence_literature NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_provenance.
- NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_assertion description "[Examples include the use of allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia with the BCR-ABL fusion gene or MLL rearrangement, and for acute myeloid leukemia with monosomy 7; antimetabolite-based therapy for acute lymphoblastic leukemia cases with hyperdiploidy of more than 50 chromosomes (DNA index > or = 1.16); and retinoic acid and anthracycline-containing regimens for the acute promyelocytic acute myeloid leukemia subtype with PML-RARA fusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1384150.RA_2CGyOQw1vFavSQubGUxSO9xzRpSLfpg3F1UQStEKCM130_provenance.